We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Medytox

News List

Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines pharmaceutical-business-review
March 26, 2021
US-based global biotechnology company Dyadic International has announced the expansion of its partnership with South Korea-based global research biopharmaceutical company Medytox to co-develop C1 manufactured Covid-19 vaccines.
Vaxine and Medytox partner on Covid-19 vaccine development pharmaceutical-technology
May 27, 2020
Australian biotechnology company Vaxine has collaborated with South Korean biopharma firm Medytox for the development and commercialisation of its Covid-19 vaccine candidate, COVAX-19.
Medytox files BLA of botulinum toxin biospectrumasia
October 15, 2018
If approved, the BTX product will be marketed locally by Medytox Taiwan, China, a joint venture between Medytox and Dynamic Medical Technologies, a Taiwan, Chinaese medical equipment company with a specialty in aesthetic lasers.